A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

UTIs in women are very common. Approximately 25-40% of women in the US aged 20 - 40 years have had a UTI. This results in over 6 million patient visits to physicians per year.

An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...

As I perused the latest edition of Georgetown’s leading publication — the Stall Seat Journal — I was pleased to see a brief ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.